🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been awarded for transformative discoveries that clarify how the body's defense network targets harmful pathogens while protecting the healthy tissues.

Three esteemed researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—received this honor.

Their work uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells capable of attacking the body.

These findings are now paving the way for new treatments for autoimmune diseases and cancer.

The laureates will share a monetary award valued at 11m Swedish kronor.

Decisive Findings

"Their research has been decisive for comprehending how the immune system operates and the reason we do not all develop serious self-attack conditions," stated the chair of the award panel.

The team's studies address a core mystery: In what way does the defense system defend us from countless infections while keeping our healthy cells unharmed?

Our body's protection system employs immune cells that scan for indicators of infection, including viruses and bacteria it has never encountered.

Such defenders employ sensors—called receptors—that are produced randomly in a vast number of combinations.

This provides the immune system the ability to combat a broad range of threats, but the unpredictability of the mechanism inevitably creates white blood cells that may attack the host.

Security Guards of the Immune System

Researchers earlier understood that some of these problematic defense cells were destroyed in the thymus—the site where white blood cells mature.

The latest award honors the identification of T-reg cells—known as the body's "peacekeepers"—which patrol the body to disarm any defenders that attack the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

A Nobel panel stated, "The findings have laid the foundation for a novel area of research and spurred the development of innovative therapies, for example for cancer and autoimmune diseases."

In cancer, regulatory T-cells prevent the system from fighting the tumor, so studies are aimed at lowering their numbers.

In autoimmune diseases, experiments are exploring boosting T-reg cells so the organism is no longer being harmed. A comparable approach could also be effective in minimizing the chances of transplanted organ rejection.

Pioneering Experiments

Prof Shimon Sakaguchi, of Osaka University, performed tests on rodents that had their thymus removed, causing self-attack conditions.

The researcher showed that introducing defense cells from healthy animals could prevent the illness—implying there was a system for preventing defenders from harming the body.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in rodents and humans that resulted in the identification of a gene vital for how regulatory T-cells function.

"The groundbreaking work has uncovered how the immune system is controlled by regulatory T cells, stopping it from accidentally attacking the body's own tissues," commented a leading biological science expert.

"This work is a remarkable example of how basic physiological study can have far-reaching implications for public health."